One study found that overexpression of EZH2 across all grades of epithelial ovarian cancer was strongly correlated (p < 0.001) with decreased overall survival (median survival of 2.5 years for EZH2 overexpression vs. 7.33 for EZH2 normal) [151]. Here, EZH2 is linked to ovarian carcinoma.